THERAPEUTIC CLASS
The Renin-Angiotensin System and Progression of Renal Disease: From Hemodynamics to Cell Biology
The renal community is faced with an ever increasing number of patients reaching end-stage renal failure. Clinical studies have provided clear evidence that angiotensin-converting enzyme (ACE) inhibitors, and probably also AT1 receptor antagonists, at least in patients suffering from type 2 diabetes, slow disease progression to end-stage renal failure.
No other version available